Plasminogen activator inhibitor-1 deficiency protects against aldosterone-induced glomerular injury

This publication has 50 references indexed in Scilit:

• Pharmacological Inhibition and Genetic Deficiency of Plasminogen Activator Inhibitor-1 Attenuates Angiotensin II/Salt-Induced Aortic Remodeling
  Arteriosclerosis, Thrombosis, and Vascular Biology, 2005
• Overexpression of Urokinase by Macrophages or Deficiency of Plasminogen Activator Inhibitor Type 1 Causes Cardiac Fibrosis in Mice
  Circulation Research, 2004
• Aldosterone and Not Plasminogen Activator Inhibitor-1 Is a Critical Mediator of Early Angiotensin II/ N ^G -Nitro- l -Arginine Methyl Ester-Induced Myocardial Injury
  Circulation, 2003
• Effects of the Selective Aldosterone Blocker Eplerenone Versus the Calcium Antagonist Amlodipine in Systolic Hypertension
  Hypertension, 2003
• Increased Carotid Wall Elastic Modulus and Fibronectin in Aldosterone-Salt–Treated Rats
  Circulation, 2002
• Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2^−ΔΔC_T Method
  Methods, 2001
• Mineralocorticoid Receptor Affects AP-1 and Nuclear Factor-κB Activation in Angiotensin II–Induced Cardiac Injury
  Hypertension, 2001
• The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure
  New England Journal of Medicine, 1999
• Angiotensin AT ₁ Receptor Subtype as a Cardiac Target of Aldosterone
  Hypertension, 1999
• Biological Determinants of Aldosterone-Induced Cardiac Fibrosis in Rats
  Hypertension, 1995